4.3 Article

Association to the Glypican-5 gene in multiple sclerosis

期刊

JOURNAL OF NEUROIMMUNOLOGY
卷 226, 期 1-2, 页码 194-197

出版社

ELSEVIER
DOI: 10.1016/j.jneuroim.2010.07.003

关键词

Multiple sclerosis; Glypican-5; Glypican-6; Genetics; Immune-mediated disease

资金

  1. University of Oslo
  2. Research Council of Norway [166005N5]
  3. South and Eastern Norway Regional Health Authority
  4. Ulleval University Hospital Scientific Advisory Council (VIRUUS)
  5. Norwegian Foundation for Health and Rehabilitation [2004/2/0125]
  6. Odd Fellow MS society
  7. Norwegian MS society, Norway
  8. DFG
  9. German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)

向作者/读者索取更多资源

Multiple sclerosis (MS) is an inflammatory, demyelinating disease affecting the central nervous system. MS-associated variants have been reported at both HLA and non-HLA loci, the latter including chromosome 13q31-32 and the Glypican-5 and Glypican-6 genes. In order to further explore the 13q31-32 region in MS, we genotyped 33 SNPs in 1355 Norwegian MS patients and 1446 Norwegian controls. An intronic SNP in the Glypican-5 gene (rs9523787) showed association with MS (P-corr = 0.006). Thus, this study supports that MS susceptibility at 13q31-32 may localize to the Glypican-5 gene, which should lead to further fine-mapping, replication and functional studies of this gene. (C) 2010 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据